Few Highlights on what to expect from HMPQ: T

Few Highlights on what to expect from HMPQ:

The massive 200-liter machine was purchased from Vitalis Extraction Technology, Inc., and represents the largest machine ever produced by the company, with an unmatched productive capacity. HempAmericana, Inc. is expecting a financial yield of between $100k to $150k in revenues per week from initial operations. However, it may not be long before those numbers are dwarfed by the productive yield of this enormous machine once it has been ramped up to full capacity. According to Company models, shareholders could reportedly benefit from an acceleration in top-line returns to an upside limit approaching $700k per week.

"The dilution has ended. Shares were previously issued to satisfy the REG A + offering, which took the better part of 15 months to receive approval from the SEC. The REG A + allows the Company to sell up to 4 Billion shares, without restrictions, at the fixed price of $0.005/share. This is a useful fundraising tool for expanding operations and will help the Company advance toward our key long-term objectives on sure capital footing. However, we are now moving rapidly in the other direction to become trim and lean on the cap table going forward," said Salvadore Rossillo, CEO.

Streamlining Share Count. In addition, the Company is pleased to report a significant reduction in total outstanding shares. The reduction of 2.25 billion shares takes the share count down from 6 billion to 3.75 billion, with aggressive plans to continue with further reductions in the very near future.

As noted in a recent release, the Company has also managed to make key strides toward nailing down a distribution network. In its December 11, 2017 press release, management went on record about its current negotiations with multiple high-volume CBD Oil producers in the US. While demand growth suggests this is not likely to be a barrier to monetization, the Company is excited to have a domestic distribution footprint in place before production commences in Maine.

Delivery of the Supercritical CO2 Extractor Machine is scheduled to take place this month.

As previously announced, the Company has negotiated Hemp raw stock purchases in sufficient quantities to allow for aggressive production targets. The raw Hemp supply is set for delivery to the Company’s principal CBD Oil production facility in Augusta, Maine before the end of January 2018.

The Company’s build-out of its Maine facility is progressing on time and will be ready for delivery of all associated production machinery and material before end of month, along with expected Permits.

As noted in a recent release, the Company has also managed to make key strides toward nailing down a distribution network. In its December 11, 2017 press release, management went on record about its current negotiations with multiple high-volume CBD Oil producers in the US. While demand growth suggests this is not likely to be a barrier to monetization, the Company is excited to have a domestic distribution footprint in place before production commences in Maine.